Gao Jing, Shen Xue, Ko Randy, Huang Cong, Shen Changbing
Department of Dermatology, the Second Affiliated Hospital, Anhui Medical University, Hefei, China.
Department of Dermatology, Chengdu Second People's Hospital, Chengdu, China.
Front Genet. 2021 Nov 26;12:735124. doi: 10.3389/fgene.2021.735124. eCollection 2021.
Psoriasis (PsO) is a chronic inflammatory skin disease that affects approximately 2% of the population all over the world. Comorbidities of PsO have increasingly garnered more interest in the past decades. Compared with the normal population, the incidences of comorbidities are higher among patients with PsO. In the last 20 years, researchers have focused on studying the genetic components of PsO, and genetic associations between PsO and its comorbidities were elucidated. This review provides an in-depth understanding and summarization of the connection between PsO and its comorbidities from the perspectives of epidemiology and genetics. Further understanding of PsO and its comorbidities will promote research on the pathogenesis, drug development, novel therapy methods, and personalized and precision treatment of PsO and its comorbidities.
银屑病(PsO)是一种慢性炎症性皮肤病,影响着全球约2%的人口。在过去几十年中,PsO的合并症越来越受到关注。与正常人群相比,PsO患者中合并症的发生率更高。在过去20年里,研究人员专注于研究PsO的遗传成分,并阐明了PsO与其合并症之间的遗传关联。本综述从流行病学和遗传学角度对PsO及其合并症之间的联系进行了深入理解和总结。对PsO及其合并症的进一步了解将促进对PsO及其合并症的发病机制、药物开发、新治疗方法以及个性化和精准治疗的研究。